FHL5 Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-27588B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Predicted:
Bovine (90%), Rat (97%). Backed by our 100% Guarantee.
Applications
Western Blot
Label
Biotin
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for FHL5 Antibody [Biotin]
Immunogen
Synthetic peptide corresponding to the N-terminus of ACT protein
Reactivity Notes
0
Localization
Nucleus
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for FHL5 Antibody [Biotin]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FHL5
Alternate Names
activator of cAMP-responsive element modulator (CREM) in testis, Activator of cAMP-responsive element modulator in testis, Activator of CREM in testis, ACTKIAA0776, dJ393D12.2, FHL-5, FLJ33049, four and a half LIM domains 5,1700027G07Rik, four and a half LIM domains protein 5, LIM protein ACT, RP3-393D12.2
Gene Symbol
FHL5
Additional FHL5 Products
Product Documents for FHL5 Antibody [Biotin]
Product Specific Notices for FHL5 Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...